Neuronal growth and plasticity is focus of top brain prize

Research on the regulation of proteins that underpin brain development and plasticity has won Professors Michael Greenberg, Christine Holt and Erin Schuman the world’s top neuroscience prize. Their pioneering work on molecular mechanisms helps us better understand how healthy brain function is maintained and casts light on the etiology of developmental and degenerative disorders.

The cellular and molecular mechanisms that guide growing axons and enable the brain to mature — and to be shaped by experience — involve activity-dependent gene transcription and the local translation of mRNA into new proteins in different neuronal compartments.

For the brain to respond to experience, its proteome must be regulated in space and time

To acknowledge the pioneering understanding of these processes gained by Professors Michael Greenberg (Harvard Medical School, Boston, USA), Christine Holt (University of Cambridge, UK) and Erin Schuman (Max Planck Institute for Brain Research, Frankfurt am Main, Germany),1-3 the Lundbeck Foundation has awarded the 2023 Brain Prize to this trio of internationally renowned researchers. 

Establishing neural connections during development and when adapting to experiences in adulthood requires brain circuits to be remodeled and maintained, explained Professor Richard Morris (University of Edinburgh, Scotland, UK), Chair of The Brain Prize Selection Committee.

 

From fundamental discoveries to therapy

This year’s Brain Prize winners have revealed how this fundamental feature of brain function is mediated at the molecular level. They help us understand how the molecular machinery needed for cells to do their job is in the right place at the right time.

We now understand better how protein synthesis is triggered in different parts of the neuron

Responding to the Award, the Prize recipients paid tribute to the invaluable role played by their co-workers and by each other, while Richard Morris explained their individual contributions in greater detail4:

  • Christine Holt was honored for work that has made the growth of retinal ganglion cell axons one of the best understood examples of axon navigation anywhere in the brain. Her research shows how the process is not exclusively controlled by the cell body, but is also influenced by local protein synthesis: mRNAs sent to the growth cones interact with external guidance cues to ensure axons take the correct path. Such knowledge will be relevant to the development of therapies for nerve repair.
  • Michael Greenberg’s award marks the culmination of a forty-year exploration of the interaction between nature, in the form of gene expression, and nurture, in the form of the environment. His insights into activity-dependent gene transcription show what is happening at the deepest molecular, cellular and circuit level; and he is finding dysregulation of these processes in neurodevelopmental disorders, such as the autism spectrum disorders. This could have major therapeutic significance.
  • The part of the puzzle revealed by Erin Schuman relates to the transport of mRNAs from the cell body to the synapses, where they are locally translated to produce the wide range of proteins needed. It is a truly remarkable discovery that this complex process of creating the proteome is occurring in these incredibly small compartments, the synapses of brain cells. The technologies required to allow its study are a major contribution.

The €1.3 million Brain Prize is the world’s largest in neuroscience

 

 

 

Celebrating outstanding science

First awarded in 2011, the annual Brain Prize is worth €1.3 million. It recognizes original and influential advances in any area of brain research, from basic neuroscience to clinical applications. Recipients now comprise 44 scientists from nine different countries. They are chosen by a selection committee of nine leading neuroscientists from all over the world.

Past prizes have been awarded for progress in diverse areas including movement circuitry,  the causes and treatment of migraine, the genetic and molecular basis of Alzheimer’s disease, the use of two-photon microscopy to provide dynamic images of activity in individual nerve cells, and fundamental brain mechanisms that link learning to reward. Winners receive the prize from His Royal Highness the Crown Prince of Denmark at a ceremony in Copenhagen.

The prize celebrates outstanding scientists. It is also an opportunity for them to explain their work to their peers and to engage the wider public in a deeper understanding of the importance, challenges and achievements of brain research.

Following the award, recipients engage in a series of seminars, lectures, and conferences organized by the Lundbeck Foundation. It is part of a process that acknowledges present achievements while inspiring new generations of researchers to pursue those of the future.

 

mRNA : messenger ribonucleic acid
UK : United Kingdom
USA : United States of America

BE-NOTPR-0293 approval date 06/2023

Our correspondent’s highlights from the symposium are meant as a fair representation of the scientific content presented. The views and opinions expressed on this page do not necessarily reflect those of Lundbeck.

References
  1. Yap E-L, Greenberg ME. Neuron. Activity-Regulated Transcription: Bridging the Gap between Neural Activity and Behavior. Neuron. 2018;100:330-348.
  2. Jung H, Yoon BC, Holt CE. Axonal mRNA localization and local protein synthesis in nervous system assembly, maintenance and repair. Nat Rev Neurosci. 2012;13:308-24.
  3. Giandomenico SL, Alvarez-Castelao B, Schuman EM. Proteostatic regulation in neuronal compartments. Trends Neurosci. 2022;45:41-52.
  4. https://lundbeckfonden.com/the-brain-prize/neuronal-transcription-translation-2023#films
You are leaving Progress in Mind
Hello
Please confirm your email
We have just sent you an email, with a confirmation link.
Before you can gain full access - you need to confirm your email.
The information on this site is exclusively intended for health care professionals.
All the information included in the Website is related to diseases, investigations and existing or potential treatment options and, therefore, directed to health professionals . The technical information of the drugs is provided merely informative, being the responsibility of the professionals authorized to prescribe drugs and decide, in each concrete case, the most appropriate treatment to the needs of the patient.
Congress
Register for access to Progress in Mind in your country